Predictive performance of automated surveillance algorithms for intravascular catheter bloodstream infections: a systematic review and meta-analysis.

Accuracy Algorithm Automated monitoring CLABSI CRBSI Healthcare associated infections Surveillance

Journal

Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411

Informations de publication

Date de publication:
31 08 2023
Historique:
received: 17 04 2023
accepted: 09 08 2023
medline: 4 9 2023
pubmed: 1 9 2023
entrez: 31 8 2023
Statut: epublish

Résumé

Intravascular catheter infections are associated with adverse clinical outcomes. However, a significant proportion of these infections are preventable. Evaluations of the performance of automated surveillance systems for adequate monitoring of central-line associated bloodstream infection (CLABSI) or catheter-related bloodstream infection (CRBSI) are limited. We evaluated the predictive performance of automated algorithms for CLABSI/CRBSI detection, and investigated which parameters included in automated algorithms provide the greatest accuracy for CLABSI/CRBSI detection. We performed a meta-analysis based on a systematic search of published studies in PubMed and EMBASE from 1 January 2000 to 31 December 2021. We included studies that evaluated predictive performance of automated surveillance algorithms for CLABSI/CRBSI detection and used manually collected surveillance data as reference. We estimated the pooled sensitivity and specificity of algorithms for accuracy and performed a univariable meta-regression of the different parameters used across algorithms. The search identified five full text studies and 32 different algorithms or study populations were included in the meta-analysis. All studies analysed central venous catheters and identified CLABSI or CRBSI as an outcome. Pooled sensitivity and specificity of automated surveillance algorithm were 0.88 [95%CI 0.84-0.91] and 0.86 [95%CI 0.79-0.92] with significant heterogeneity (I Performance of automated algorithms for detection of intravascular catheter infections in comparison to manual surveillance seems encouraging. The development of automated algorithms should consider the inclusion of results of microbiological cultures from specific specimens to exclude non-CRBSI, while the inclusion of clinical data may not have an added-value. Trail Registration Prospectively registered with International prospective register of systematic reviews (PROSPERO ID CRD42022299641; January 21, 2022). https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022299641.

Sections du résumé

BACKGROUND
Intravascular catheter infections are associated with adverse clinical outcomes. However, a significant proportion of these infections are preventable. Evaluations of the performance of automated surveillance systems for adequate monitoring of central-line associated bloodstream infection (CLABSI) or catheter-related bloodstream infection (CRBSI) are limited.
OBJECTIVES
We evaluated the predictive performance of automated algorithms for CLABSI/CRBSI detection, and investigated which parameters included in automated algorithms provide the greatest accuracy for CLABSI/CRBSI detection.
METHODS
We performed a meta-analysis based on a systematic search of published studies in PubMed and EMBASE from 1 January 2000 to 31 December 2021. We included studies that evaluated predictive performance of automated surveillance algorithms for CLABSI/CRBSI detection and used manually collected surveillance data as reference. We estimated the pooled sensitivity and specificity of algorithms for accuracy and performed a univariable meta-regression of the different parameters used across algorithms.
RESULTS
The search identified five full text studies and 32 different algorithms or study populations were included in the meta-analysis. All studies analysed central venous catheters and identified CLABSI or CRBSI as an outcome. Pooled sensitivity and specificity of automated surveillance algorithm were 0.88 [95%CI 0.84-0.91] and 0.86 [95%CI 0.79-0.92] with significant heterogeneity (I
CONCLUSIONS
Performance of automated algorithms for detection of intravascular catheter infections in comparison to manual surveillance seems encouraging. The development of automated algorithms should consider the inclusion of results of microbiological cultures from specific specimens to exclude non-CRBSI, while the inclusion of clinical data may not have an added-value. Trail Registration Prospectively registered with International prospective register of systematic reviews (PROSPERO ID CRD42022299641; January 21, 2022). https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022299641.

Identifiants

pubmed: 37653559
doi: 10.1186/s13756-023-01286-0
pii: 10.1186/s13756-023-01286-0
pmc: PMC10468855
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

87

Investigateurs

Carlo Balmelli (C)
Delphine Berthod (D)
Jonas Marschall (J)
Hugo Sax (H)
Matthias Schlegel (M)
Alexander Schweiger (A)
Laurence Senn (L)
Rami Sommerstein (R)
Nicolas Troillet (N)
Danielle Vuichard Gysin (DV)
Andreas F Widmer (AF)
Aline Wolfensberger (A)
Walter Zingg (W)

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Suetens C, Latour K, Kärki T, Ricchizzi E, Kinross P, Moro ML, et al. Healthcare-Associated Infections Prevalence Study Group. Prevalence of healthcare-associated infections estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill. 2018;23(46):1800516. Erratum in: Euro Surveill. 2018;23(47).
Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, Weist K, et al. National Contact Points for the ECDC pilot point prevalence survey; Hospital Contact Points for the ECDC pilot point prevalence survey. The european centre for disease prevention and control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill. 2012;17(46):20316.
Schreiber PW, Sax H, Wolfensberger A, Clack L, Kuster SP, Swissnoso. The preventable proportion of healthcare-associated infections 2005–2016: Systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2018;39(11):1277–95.
European Centre for Disease Prevention and Control. Healthcare-associated infections in intensive care units - Annual Epidemiological Report for 2017. ECDC; 2019. https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2017-HAI.pdf .
Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg. 2001;136:229.
doi: 10.1001/archsurg.136.2.229 pubmed: 11177147
Olaechea PM, Palomar M, Álvarez-Lerma F, Otal JJ, Insausti J, López-Pueyo MJ, ENVIN-HELICS Group. Morbidity and mortality associated with primary and catheter-related bloodstream infections in critically ill patients. Rev Esp Quimioter. 2013;26:21–9.
Ziegler MJ, Pellegrini DC, Safdar N. Attributable mortality of central line associated bloodstream infection: systematic review and metaanalysis. Infection. 2015;43:29–36.
doi: 10.1007/s15010-014-0689-y pubmed: 25331552
Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173:2039–46.
doi: 10.1001/jamainternmed.2013.9763 pubmed: 23999949
Stevens V, Geiger K, Concannon C, Nelson RE, Brown J, Dumyati G. Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections. Clin Microbiol Infect. 2014;20(5):318–24.
doi: 10.1111/1469-0691.12407
Bae S, Kim Y, Chang HH, Kim S, Kim HJ, Jeon H, et al. The effect of the multimodal intervention including an automatic notification of catheter days on reducing central line-related bloodstream infection: a retrospective, observational, quasi-experimental study. BMC Infect Dis. 2022;22(1):604.
doi: 10.1186/s12879-022-07588-9 pubmed: 35804323 pmcid: 9270824
van Mourik MSM, van Rooden SM, Abbas M, Aspevall O, Astagneau P, Bonten MJM, et al. PRAISE network. PRAISE: providing a roadmap for automated infection surveillance in Europe. Clin Microbiol Infect. 2021;27 (Suppl 1):S3-S19.
Verberk JDM, Aghdassi SJS, Abbas M, Nauclér P, Gubbels S, Maldonado N, et al. Automated surveillance systems for healthcare-associated infections: results from a European survey and experiences from real-life utilization. J Hosp Infect. 2022;122:35–43.
doi: 10.1016/j.jhin.2021.12.021 pubmed: 35031393
Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses. BMJ. 2009;339:b2535.
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022299641 .
Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009;49(1):1–45.
doi: 10.1086/599376 pubmed: 19489710
Timsit JF, Baleine J, Bernard L, Calvino-Gunther S, Darmon M, Dellamonica J, et al. Expert consensus-based clinical practice guidelines management of intravascular catheters in the intensive care unit. Ann Intensive Care. 2020;10(1):118.
doi: 10.1186/s13613-020-00713-4 pubmed: 32894389 pmcid: 7477021
Buetti N, Timsit JF. Management and prevention of central venous catheter-related infections in the ICU. Semin Respir Crit Care Med. 2019;40(4):508–23.
doi: 10.1055/s-0039-1693705 pubmed: 31585477
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
doi: 10.1002/sim.1186 pubmed: 12111919
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
doi: 10.1136/bmj.327.7414.557 pubmed: 12958120 pmcid: 192859
Dwamena BA. MIDAS: Stata module for meta-analytical integration of diagnostic test accuracy studies. Statistical Software Components. 2007. https://econpapers.repec.org/RePEc:boc:bocode:s456880 .
Trick WE, Zagorski BM, Tokars JI, Vernon MO, Welbel SF, Wisniewski MF, et al. Computer algorithms to detect bloodstream infections. Emerg Infect Dis. 2004;10(9):1612–20.
doi: 10.3201/eid1009.030978 pubmed: 15498164 pmcid: 3320282
Bellini C, Petignat C, Francioli P, Wenger A, Bille J, Klopotov A, et al. Comparison of automated strategies for surveillance of nosocomial bacteremia. Infect Control Hosp Epidemiol. 2007;28(9):1030–5.
doi: 10.1086/519861 pubmed: 17932822
Woeltje KF, Butler AM, Goris AJ, Tutlam NT, Doherty JA, Westover MB, et al. Automated surveillance for central line-associated bloodstream infection in intensive care units. Infect Control Hosp Epidemiol. 2008;29(9):842–6.
doi: 10.1086/590261 pubmed: 18713052 pmcid: 6788749
Woeltje KF, McMullen KM, Butler AM, Goris AJ, Doherty JA. Electronic surveillance for healthcare-associated central line-associated bloodstream infections outside the intensive care unit. Infect Control Hosp Epidemiol. 2011;32(11):1086–90.
doi: 10.1086/662181 pubmed: 22011535
Snyders RE, Goris AJ, Gase KA, Leone CL, Doherty JA, Woeltje KF. Increasing the reliability of fully automated surveillance for central line-associated bloodstream infections. Infect Control Hosp Epidemiol. 2015;36(12):1396–400.
doi: 10.1017/ice.2015.199 pubmed: 26329691
Streefkerk H, Roel A, VerkooijenRoel PAJ, BramerWichor M, Verbrugh HA. Electronically assisted surveillance systems of healthcare-associated infections: a systematic review. Euro Surveill. 2020. https://doi.org/10.2807/1560-7917.ES.2020.25.2.1900321 .
doi: 10.2807/1560-7917.ES.2020.25.2.1900321 pubmed: 31964462 pmcid: 6976884
Cosentino CB, Mitchell BG, Brewster DJ, Russo PL. The utility of frailty indices in predicting the risk of health care associated infections: a systematic review. Am J Infect Control. 2021;49(8):1078–84.
doi: 10.1016/j.ajic.2020.12.001 pubmed: 33309842
van Mourik MS, van Duijn PJ, Moons KG, Bonten MJ, Lee GM. Accuracy of administrative data for surveillance of healthcare-associated infections: a systematic review. BMJ Open. 2015;5(8): e008424.
doi: 10.1136/bmjopen-2015-008424 pubmed: 26316651 pmcid: 4554897
Ward MA, Schweizer ML, Polgreen PM, Gupta K, Reisinger HS, Perencevich EN. Automated and electronically assisted hand hygiene monitoring systems: a systematic review. Am J Infect Control. 2014;42(5):472–8.
doi: 10.1016/j.ajic.2014.01.002 pubmed: 24773785
Peterson LR, Smith BA. Nonutility of catheter tip culture for diagnosis of central line-associated bloodstream infection. Clin Infect Dis. 2015;60(3):492–3.
doi: 10.1093/cid/ciu845 pubmed: 25355902
Peres Bota D, Mélot C, Lopes Ferreira F, Vincent JL. Infection Probability Score (IPS): a method to help assess the probability of infection in critically ill patients. Crit Care Med. 2003;31:2579–84.
doi: 10.1097/01.CCM.0000094223.92746.56 pubmed: 14605527
Schalk E, Hanus L, Färber J, Fischer T, Heidel FH. Prediction of central venous catheter–related bloodstream infections (CRBSIs) in patients with haematologic malignancies using a modified Infection Probability Score (mIPS). Ann Hematol. 2015;94:1451–6.
doi: 10.1007/s00277-015-2387-y pubmed: 25933677
Snell KI, Ensor J, Debray TP, Moons KG, Riley RD. Meta-analysis of prediction model performance across multiple studies: Which scale helps ensure between-study normality for the C-statistic and calibration measures? Stat Methods Med Res. 2018;27(11):3505–22.
doi: 10.1177/0962280217705678 pubmed: 28480827

Auteurs

Jean-Marie Januel (JM)

Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Service PCI, Rue Gabrielle-Perret-Gentil 4, 1205, Geneve, Switzerland. jean-marie.januel@hotmail.com.

Nasim Lotfinejad (N)

Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Service PCI, Rue Gabrielle-Perret-Gentil 4, 1205, Geneve, Switzerland.

Rebecca Grant (R)

Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Service PCI, Rue Gabrielle-Perret-Gentil 4, 1205, Geneve, Switzerland.

Sarah Tschudin-Sutter (S)

Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, Switzerland.

Peter W Schreiber (PW)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Bruno Grandbastien (B)

Service of Hospital Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland.

Philipp Jent (P)

Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.

Elia Lo Priore (E)

Department of Infectious Diseases and Hospital Epidemiology, EOC Regional Hospital of Lugano, Lugano, Switzerland.

Alexandra Scherrer (A)

Swissnoso, National Center for Infection Control, Bern, Switzerland.

Stephan Harbarth (S)

Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Service PCI, Rue Gabrielle-Perret-Gentil 4, 1205, Geneve, Switzerland.

Gaud Catho (G)

Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Service PCI, Rue Gabrielle-Perret-Gentil 4, 1205, Geneve, Switzerland.
Division of Infectious Diseases, Central Institute, Valais Hospital, Sion, Switzerland.

Niccolò Buetti (N)

Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Service PCI, Rue Gabrielle-Perret-Gentil 4, 1205, Geneve, Switzerland.
Université de Paris, INSERM, IAME UMR 1137, 75018, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH